MedTrace Logo

Beta-2 Microglobulin and Serum Cytokines x HAART

NCT00831207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2009-01-28

No results posted yet for this study

Summary

Cross-sectional study to assess the behavior of Beta-2 microglobulin and serum cytokines TNF-α, IFN-γ, IL-2, IL-4 and IL-10 as indicators of highly active antiretroviral therapy (HAART) failure.

Conditions

  • HIV Patients

Sponsors & Collaborators

  • Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil

    collaborator OTHER

  • UPECLIN HC FM Botucatu Unesp

    lead OTHER

Principal Investigators

  • Ricardo MB Almeida, MSc · Departamento de Doencas Tropicais e Diagnostico por Imagem - Faculdade de Medicina de Botucatu - UNESP.

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2005-11-30
Completion
2008-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00831207 on ClinicalTrials.gov